Abstract:ObJective To study the hypothalamic-pituitary-adrenal (HPA) axis function with dexamethasone suppression test (DST) in inpatients with unipolar depression or bipolar disorder at different mood states. Methods DST was performed in 38 inpatients with unipolar depression and 63 with bipolar disorder ([19 with type Ⅰ, 44 with type Ⅱ], [33 with depressive episode, 18 with manic episode and 12 with combined episodes]). After 4 weeks' treatment, DST was performed again on 17 patients with unipolar depression and 35 with bipolar disorder to compare the negative suppression ratio. Results Before treatment, the negative suppression rate of DST was significantly different between unipolar depression (36.8%) and bipolar disorder (14.3%), type Ⅰ bipolar disorder (10.5%), type Ⅱ bipolar disorder (15.9%) or bipolar disorder with current depressive episode (15.2%) (P<0.05). However, no statistic differences were showed among type Ⅰ bipolar disorder and type Ⅱ bipolar disorder, depressive episode of bipolar disorder (15.2%), manic episode of bipolar disorder (16.7%) or combined episodes of bipolar disorder (11.1%) (P>0.05). After treatment, the same comparison was performed, but negative suppression rate of DST was not significantly different among all the groups (P>0.05). With the clinical improvement, negative suppression rate of DST decreased in patients with unipolar disorder;while no significant differences were found between pre-treatment and post-treatment in patients with both unipolar and bipolar disorders (P>0.05). Conclusion At the status of illness, the negative suppression rate of DST in the unipolar depression, being independent from the clinical subtypes, types of episode and severity of the illness in bipolar disorder, is much higher than that in the bipolar disorder.

Use of the dexamethasone suppression test in an inpatient setting: A replication and new findings

Repeated Dexamethasone Suppression Test in Major Depression.

Repeated Dexamethasone Suppression Test in Depressed-Patients

The Cortisol Suppression Index and the Dexamethasone Suppression Test in Major Depression.

The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and relationships between post-dexamethasone cortisol and ACTH levels

Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.

Dexamethasone Suppression Test in Inpatients with Unipular Depression or Bipolar Disorder:A Comparison Study

Results of the 8 A.m. Dexamethasone Suppression Test Constitute a Suitable Tool for Confirming the Diagnosis of Melancholia

Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.

Adrenocorticotropic hormone, β-endorphin and cortisol responses to oCRH in Unipolar Depressed Patients Pretreated with Dexamethasone

An augmented escape of β-endorphins to suppression by dexamethasone in severely depressed patients

The Dexamethasone Suppression Test, the Hamilton Depression Rating Scale and the DSM-III Depression Categories

L-5-Hydroxytryptophan Stimulated Cortisol Escape from Dexamethasone Suppression in Melancholic Patients

Postdexamethason Intact and Multisequentia ACTH in Melancholia.

A further investigation of basal HPT axis function in unipolar depression: effects of diagnosis, hospitalization, and dexamethasone administration.

Suppressive effects of dexamethasone on hypothalamic-pituitary-thyroid axis function in depressed patients

A revised interpretation of postdexamethasone ACTH and cortisol findings in unipolar depressed females.

In Search of the HPA Axis Activity in Unipolar Depression Patients with Childhood Trauma: Combined Cortisol Awakening Response and Dexamethasone Suppression Test

A Study of Dexamethasone Suppression Test in Patients with Obsessive-Compulsive Disorder

Serum postdexamethasone prolactin measures in depressive patients and control subjects

A Multivariate Study of Simultaneous Escape from Suppression by Dexamethasone of Urinary Free Cortisol, Plasma Cortisol, Adrenocorticotropic Hormone and Beta-Endorphin in Melancholic Patients.